Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.20.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities      
Net income (loss) $ 82,759 $ 81,920 $ 41,798
Adjustments to reconcile net income to net cash provided by operating activities:      
Provision for loss on receivables 10,096 8,027 0
Depreciation and amortization 3,580 3,593 4,526
Amortization of financing costs 7,789 6,435 10,727
Equity-based compensation 16,791 14,160 10,066
Equity method investments 13,099 (34,392) 4,312
Non-cash gain on securitization (55,413) (56,717) (25,728)
Gain on sale of receivables and investments 13,811 13,241 0
Changes in receivables held-for-sale 0 0 12,685
Loss on debt extinguishment 0 0 9,245
Changes in accounts payable and accrued expenses 8,023 5,184 6,882
Accrued interest and other (27,253) (11,962) (15,720)
Net cash provided by operating activities 73,282 29,489 58,793
Cash flows from investing activities      
Equity method investments (885,862) (152,096) (76,349)
Equity method investment distributions received 98,571 71,183 88,160
Proceeds from sales of equity method investments 0 81,297 35,849
Purchases of and investments in receivables (256,323) (497,866) (292,834)
Principal collections from receivables 132,958 57,670 345,956
Proceeds from sales of receivables 59,398 134,932 0
Purchases of real estate 0 0 (27,549)
Purchases of investments (40,185) (45,830) (25,308)
Principal collections from investments 2,424 6,626 5,252
Proceeds from sales of investments and securitization assets 68,520 139,230 0
Funding of escrow accounts (23,178) (28,953) (34,980)
Withdrawal from escrow accounts 8,094 30,707 33,108
Other 3,931 1,959 (505)
Net cash provided by (used in) investing activities (831,652) (201,141) 50,800
Cash flows from financing activities      
Proceeds from credit facilities 126,000 101,500 171,783
Principal payments on credit facilities (134,594) (328,465) (46,604)
Proceeds from issuance of non-recourse debt 15,938 130,988 69,255
Principal payments on non-recourse debt (125,969) (206,705) (390,537)
Proceeds from issuance of senior unsecured notes 771,250 507,313 0
Proceeds from issuance of convertible notes 143,750 0 0
Payments on deferred funding obligations (629) (18,791) (73,946)
Net proceeds of common stock issuances 298,070 138,383 187,265
Payments of dividends and distributions (99,867) (86,406) (70,989)
Withholdings on employee share vesting (17,287) (9,168) (3,053)
Other (14,547) (9,764) (11,591)
Net cash provided by (used in) financing activities 962,115 218,885 (168,417)
Increase (decrease) in cash, cash equivalents, and restricted cash 203,745 47,233 (58,824)
Cash, cash equivalents, and restricted cash at beginning of period 106,586 59,353 118,177
Cash, cash equivalents, and restricted cash at end of period 310,331 106,586 59,353
Supplemental Cash Flow Information [Abstract]      
Interest paid 75,934 48,056 72,078
Non-cash changes in deferred funding obligations and non-recourse debt (financing activity) 0 (112,027) (6,973)
Non-cash changes in receivables and investments (investing activity) 0 93,730 (248)
Non-cash changes in residual assets (investing activity) $ (56,967) $ (61,001) $ (25,827)